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Abstract: The production of chiral amines by transaminase-catalyzed amination of ketones is an
important application of biocatalysis in synthetic chemistry. It requires transaminases that show
high enantioselectivity in asymmetric conversion of the ketone precursors. A robust derivative of
ω-transaminase from Pseudomonas jessenii (PjTA-R6) that naturally acts on aliphatic substrates was
constructed previously by our group. Here, we explore the catalytic potential of this thermostable
enzyme for the synthesis of optically pure aliphatic amines and compare it to the well-studied
transaminases from Vibrio fluvialis (Vf TA) and Chromobacterium violaceum (CvTA). The product yields
indicated improved performance of PjTA-R6 over the other transaminases, and in most cases,
the optical purity of the produced amine was above 99% enantiomeric excess (e.e.). Structural analysis
revealed that the substrate binding poses were influenced and restricted by the switching arginine and
that this accounted for differences in substrate specificities. Rosetta docking calculations with external
aldimine structures showed a correlation between docking scores and synthetic yields. The results
show that PjTA-R6 is a promising biocatalyst for the asymmetric synthesis of aliphatic amines with a
product spectrum that can be explained by its structural features.
Keywords: transamination; asymmetric synthesis; alkanamines; transaminase; computational modeling
1. Introduction
Optically pure amines are of great interest for the pharmaceutical and wider fine chemical
industries as they can serve as intermediates in the preparation of a diversity of biologically
active compounds [1–3]. For example, chiral amines are used as building blocks in the synthesis of
pharmaceuticals used in the treatment of Alzheimer’s disease [4] and malaria [5] or as antitumor
agents [6]. The enzymatic production of such amines is widely studied for furthering the application
of biocatalysis in environmentally benign synthetic processes [7,8].
Transaminases (TAs) catalyze the transfer of amino groups from amines (amino donors)
to aldehydes or ketones (amino acceptors), with pyridoxal-5′ phosphate (PLP) as the cofactor
(Scheme 1) [2,9]. Whereas α-transaminases act on substrates bearing a carboxylate group flanking
the carbon carrying the amine functionality that is exchanged, ω-transaminases (ω-TAs) act on
nonproteinogenic amino acids with the amine and carboxylate groups at terminal positions. Many
ω-TAs and related enzymes are called amine transaminases (ATAs) as they act on substrates that lack a
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carboxylate functionality. This relaxed substrate specificity allows amination of various ketones when
added as amino acceptor [10]. Mechanistically, in the first half reaction, the amino donor aminates the
PLP to form a pyridoxamine intermediate (PMP) in several proton transfer steps. In the second half
reaction, the ketone acceptor binds to the PMP enzyme to form the aminated product and regenerate
PLP (Scheme 1). Recent efforts to tailor theω-TA substrate scope have focused on stabilization of the
Michaelis complex of the ketone substrate [11–14] with little or no attention to reaction intermediates.
The external aldimine is a key intermediate in the transamination reaction. Depending on the half
reaction under consideration, the external aldimine can either undergo proton abstraction by the
catalytic lysine to form a quinonoid intermediate or abstract a proton from lysine to form a geminal
diamine intermediate [15]. Both formation and conversion of the external aldimine go through the
formation of high-energy transition state structures, and their corresponding reactions are rate-limiting.
Therefore, we hypothesized that substrates capable of forming more stable external aldimine complexes
would overall have better reactivities.
Scheme 1. ω-Transaminase-catalyzed transamination with isopropylamine as the amino donor.
The aldehyde/ketone substrate will bind to the pyridoxamine intermediate (PMP) enzyme to form an
external aldimine. The relatively large (RL) or small (RS) ketone/amine rest groups are accommodated
in the large or small binding pockets of the transaminase. The excess of isopropylamine drives the
equilibrium toward the production of the target amine.
Prior work on the catalytic abilities of ω-TAs indicates versatile substrate spectra and (S)- or
(R)-enantioenrichment of amines formed by conversion of prochiral ketones [16]. Compared with
traditional chemical synthesis, harsh conditions and heavy metal catalysts are avoided by enzymatic
reactions, displaying the green aspects of biocatalysis [3,7]. Moreover, the use of cheap amine
donors or regeneration of the amine donor in TA-catalyzed amination enables one-pot asymmetric
synthesis [3,17]. Therefore, the production of optically pure amines applying ω-TAs is considered
promising from an application point of view. A large variety of transaminases that are active in
the enzymatic synthesis of aromatic amines have been described [16]. In comparison, biocatalytic
synthesis of chiral aliphatic amines is not well studied, and reports on asymmetric synthesis of
aliphatic amines by TAs are scarce [16]. Nonetheless, aliphatic amines are frequently seen as important
intermediates of pharmaceuticals and other biologically active compounds [7,18]. Thus, transaminases
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capable of producing various enantiopure aliphatic amines would diversify and strengthen the
biocatalytic toolbox.
Apart from the need for an active enzyme for aliphatic amine synthesis, there are also several
technical challenges concerning TA-catalyzed amine production. First, the reaction equilibrium
needs to be shifted from the amino donor toward the production of the target amines. Often, this
is achieved using an excess of the amino donor, sometimes accompanied by the removal of the side
product [7,16,19,20]. Second, to use and fully dissolve a high concentration of the ketone substrate that
should undergo amination, a cosolvent is sometimes added [1,21]. Besides overcoming equilibrium
issues, the reaction rate may need to be accelerated using a high temperature. The availability of a
robustω-TA is desired in such scenarios of high amino donor concentrations, presence of cosolvents,
and high reaction temperatures [3].
The discovery [22] and characterization [23] of a class III (S)-selective ω-TA from Pseudomonas
jessenii (PjTA) were described previously. Identified as a key enzyme in the caprolactam degradation
pathway of P. jessenii, PjTA converts 6-aminohexanoic acid (6-AHA) to 6-oxohexanoic acid (6-OHA).
Our group has deepened the understanding of this enzyme by solving crystal structures and measuring
its activities using over 40 different amine substrates [23]. A robust six-fold mutant of PjTA (PjTA-R6)
was recently constructed using a framework for rapid enzyme stabilization by computational library
design (FRESCO) [24]. The natural substrate of PjTA is a linear aliphaticω-amino acid, which suggests
PjTA may have potential for the synthesis of aliphatic amines. Moreover, the robust mutant PjTA-R6 is
expected to tolerate a high concentration of amino donor, the presence of cosolvent, and an enhanced
reaction temperature [24]. Thus, in the work reported here, we explored PjTA-R6 for the synthesis
of aliphatic amines for which the wild-type PjTA was not considered as attractive due to its lower
stability under harsh conditions. Considering their structural diversity and similarity to pharmaceutical
building blocks, 10 aliphatic amines were selected for enzymatic production [8,18]. This included two
amines with cycloalkyl substituents (C1 and C2 in Table 1).
Table 1. Analytical yields and enantiomeric excesses for the production of A1–A5, B1–B3, and C1–C2
using a six-fold mutant of transaminase from Pseudomonas jessenii (PjTA-R6), a transaminase from
Chromobacterium violaceum (CvTA), and a transaminase from Vibrio fluvialis (Vf TA).1
Amine
Target Code Amine Structure
PjTA-R6 CvTA VfTA
Yield 1 (%) e.e. 2 (%) Yield (%) e.e. (%) Yield (%) e.e. (%)
A1
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Table 1. Cont.
Amine
Target Code Amine Structure
PjTA-R6 CvTA VfTA
Yield 1 (%) e.e. 2 (%) Yield (%) e.e. (%) Yield (%) e.e. (%)
B2




81 >99 3 n.d. 2 n.d. 
B3 
 
48 >99 <1 n.d. 2 n.d. 
C1 
 
42 >99 1 n.d. <1 n.d. 
C2 
 
63 >99 <1 n.d. 1 n.d. 
Reaction conditions: 1 mL volume, 20 mM ketone substrate, 1 M isopropylamine, 0.5 mM pyridoxal-
5′ phosphate (PLP), 1 mg/mL purified transaminase, 2% dimethyl sulfoxide (DMSO) (20% for A5), 20 
h, 56 °C for PjTA-R6 and 37 °C for CvTA and VfTA. 1 The yields obtained with PjTA-R6 are the 
averages of duplicates that differed less than 10%. 2 e.e.: enantiomeric excess. 3 n.d.: not 
determined.enzymes. Noticeably, after 20 h of reaction, an enzyme precipitate was observed in the 
vials containing CvTA and VfTA but not in the reaction mixtures containing PjTA-R6. This agreed 
with our expectation that PjTA-R6 would be more robust than the other two transaminases at high 
reaction temperature with excess amino donor present. 
To compare the performance of PjAT-R6 to other well-characterized (S)-selective TAs, we 
included the enzymes from Chromobacterium violaceum (CvTA) and Vibrio fluvialis (VfTA). Through a 
systematic analysis of the substrate spectrum of various transaminases reported in different papers, 
Calvelage et al. [25] concluded that CvTA and VfTA have advantages in converting straight-chain 
amines over other transaminases. The relative performance of PjTA-R6 in comparison to CvTA and 
VfTA may help to evaluate the enzyme in terms of its significance within the enzymatic toolbox. 
Under the employed conditions, the yields of aliphatic amines obtained with PjTA-R6 were higher 
than with CvTA or VfTA, and the enantiopurity of the produced amines was also higher. 
Aiming to understand the structural basis for the observed reactivities of PjTA-R6 and VfTA, we 
performed docking calculations of the external aldimine complexes of the tested substrates. For both 
enzymes, the interface energies of the external aldimine complexes correlated well with experimental 
reaction yields, indicating that biocatalytic scope can be accessed computationally for further 
redesign attempts. The docking complexes hinted to pivotal structural differences in the way PjTA-
R6 and VfTA accommodate bulky or alkyl chains in the large substrate binding pocket. 
2. Results and Discussion 
2.1. Asymmetric Synthesis of Aliphatic Amines 
To investigate the performance of PjTA-R6 in the asymmetric synthesis of aliphatic amines and 
compare the results with CvTA and VfTA, amination reactions were conducted using the three 
enzymes and a series of keto substrates (Table 1). For these amination reactions, we adopted 
conditions with a 50-fold excess of isopropylamine (IPA) as the amino donor (Scheme 1). This amino 
donor is relatively cheap [7] and highly water soluble, making its use in enzymatic aminations 
economically attractive. Moreover, IPA is transformed to acetone, whose volatility may simplify the 
work-up procedure [26]. The reaction temperature was 56 °C for PjTA-R6, given its high 
thermostability, and 37 °C for CvTA and VfTA. Protein concentrations were the same for all three 
The asymmetric synthesis of aliphatic amines was successful as all ketone substrates were 
converted by PjTA-R6 and yielded predominantly (S)-amines with all yields exceeding 40% (Table 
1). Whereas equilibrium may have been approached in some reactions (e.g., B1 with PjTA), the lower 
yields with most other substrates and especially in reactions catalyzed by CvTA and VfTA indicate 
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h, 56 °C for PjTA-R6 and 37 °C for CvTA and VfTA. 1 The yields obtained with PjTA-R6 are the 
averages of duplicates that differed less than 10%. 2 e.e.: enantiomeric excess. 3 n.d.: not 
determined.enzymes. Noticeably, after 20 h of reaction, an enzyme precipitate was observed in the 
vials containing CvTA and VfTA but not in the reaction mixtures containing PjTA-R6. This agreed 
with our expectation that PjTA-R6 would be more robust than the other two transaminases at high 
reaction temperature with excess amino donor present. 
To compare the performance of PjAT-R6 to other well-characterized (S)-selective TAs, we 
included the enzymes from Chromobacterium violaceum (CvTA) and Vibrio fluvialis (VfTA). Through a 
systematic analysis of the substrate spectrum of various transaminases reported in different papers, 
Calvelage et al. [25] concluded that CvTA and VfTA have advantages in converting straight-chain 
amines over other transaminases. The relative performance of PjTA-R6 in comparison to CvTA and 
VfTA may help to evaluate the enzyme in terms of its significance within the enzymatic toolbox. 
Under the employed conditions, the yields of aliphatic amines obtained with PjTA-R6 were higher 
than with CvTA or VfTA, and the enantiopurity of the produced amines was also higher. 
Aiming to understand the structural basis for the observed reactivities of PjTA-R6 and VfTA, we 
performed docking calculations of the external aldimine complexes of the tested substrates. For both 
enzymes, the interface energies of the external aldimine complexes correlated well with experimental 
reaction yields, indicating that biocatalytic scope can be accessed computationally for further 
redesign attempts. The docking complexes hinted to pivotal structural differences in the way PjTA-
R6 and VfTA accommodate bulky or alkyl chains in the large substrate binding pocket. 
2. Results and Discussion 
2.1. Asymmetric Synthesis of Aliphatic Amines 
To investigate the performance of PjTA-R6 in the asymmetric synthesis of aliphatic amines and 
compare the results with CvTA and VfTA, amination reactions were conducted using the three 
enzymes and a series of keto substrates (Table 1). For these amination reactions, we adopted 
conditions with a 50-fold excess of isopropylamine (IPA) as the amino donor (Scheme 1). This amino 
donor is relatively cheap [7] and highly water soluble, making its use in enzymatic aminations 
economically attractive. Moreover, IPA is transformed to acetone, whose volatility may simplify the 
work-up procedure [26]. The reaction temperature was 56 °C for PjTA-R6, given its high 
thermostability, and 37 °C for CvTA and VfTA. Protein concentrations were the same for all three 
The asymmetric synthesis of aliphatic amines was successful as all ketone substrates were 
converted by PjTA-R6 and yielded predominantly (S)-amines with all yields exceeding 40% (Table 
1). Whereas equilibrium may have been approached in some reactions (e.g., B1 with PjTA), the lower 
yields with most other substrates and especially in reactions catalyzed by CvTA and VfTA indicate 
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Reaction conditions: 1 mL volume, 20 mM ketone substrate, 1 M isopropylamine, 0.5 mM pyridoxal-5′ phosphate
(PLP), 1 mg/mL purified transaminase, 2% dim thyl sulfoxide (DMSO) (20% for A ), 20 h, 56 ◦C for PjTA-R6 and
37 ◦C for CvTA and Vf TA. 1 The yields obtained with PjTA-R6 are the averages of duplicates that differed less than
10%. 2 e.e.: enantiomeric excess. 3 n.d.: not etermined.enzyme . Not ceably, after 20 h of reaction, an enzyme
p ecipitate was observed in he vials containing CvTA and Vf TA but not n the reaction mixtures co taining PjTA-R6.
This agreed with our expectation that PjTA-R6 would be more robust than the other two transaminases at high
r a tion temperature with excess amino donor present.
To compare he performance of PjAT-R6 to other well-characterized (S)-selective TAs, we included
the enzy es from Chromobacterium violaceum (CvTA) and Vibrio fluvialis (Vf TA). Through a systematic
analysis of the substrate spectrum of various transaminases reported in different papers, Calvelage
et al. [25] concluded that CvTA and Vf TA h ve adv t ges in converting straight-chain amines over
oth r trans minases. The relative performance of PjTA-R6 in comparison o CvTA and Vf TA may help
to evaluate enzyme i t rms of its significance within the enzymatic toolbox. Under the employed
conditions, the yields of aliphatic ami es obtained with PjTA-R6 were igher than with CvTA or Vf TA,
and the enantiopurity of the produced amines was also higher.
Aiming t understand h struct al basis f the observed re ctivities of PjTA-R6 and Vf TA, we
performe docking calculati ns of the external aldimine complexes of the tested substrates. For both
enzymes, the interface energies of the external aldimine complexes correlated well with experimental
reaction yields, indicating that bioc talytic scope can be accessed computationally for further redesign
attempts. The docking omplexes hinted to pivotal struct ral differences in the way PjTA-R6 and Vf TA
accommod te bulky or alkyl chains in the large substrate binding pocket.
2. Results and Di cussion
2 1. Asymmetric Synthesis of Al phat c Amines
To investigat the performance of PjTA-R6 in the asymmetric synthesis of aliphatic amines and
compare the results with CvTA and VfTA, amination reactions w re conducted using the three enzymes
a d a eries of ket substrates (Tabl 1). For these amination re cti ns, we adopted c nditions with a
50-fold excess of isopropyl mine (IPA) as the amino donor (Scheme 1). This amino don r is relatively
cheap [7] and highly water soluble, making its use in enzymatic aminations economically attractive.
Moreover, IPA is transformed to acetone, whos volatility may simplify the work-up procedure [26].
The reaction temperature was 56 ◦C or PjTA-R6, given i s high thermostability, and 37 ◦C for CvTA
and Vf TA. Protein co centrations were the same for all three.
The asymmetric s nth sis of alipha ic amines was successful as all ketone su strates were
converted by PjTA-R6 and yielded predominantly (S)-amines with all yields exceeding 40% (Table 1).
Whereas equilibrium may have b en approached i some r actions (e.g., B1 with PjTA), the lower
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yields with most other substrates and especially in reactions catalyzed by CvTA and Vf TA indicate
that differences in yields were mainly determined by kinetics. In particular, amines A1 and A2 and
branched amines B1 and B2 were well synthesized by PjTA-R6. Noticeably, using PjTA-R6, cyclic amine
C2, carrying a cyclohexyl group substituent, was better synthesized than C1, which has a cyclopropyl
group. This suggested that the general bulkiness of the larger substrate did not limit conversion. Chiral
analysis of the amines formed by PjTA-R6 confirmed the expected (S)-enantioenrichment, and all
amines were produced at high enantiomeric excess (e.e.). The enantiopurities of the products indicated
a dependence on the difference in size between the large (RL) and small (RS = –CH3) side substituents
on the carbonyl carbon of the substrates. A1 (RL = –CH2CH3) and A2 (RL = –CH2CH2CH3) were
produced with 94% and 98% e.e., respectively, while all the other amines were produced with >99% e.e.
Under the employed conditions, the yields of straight-chain amines (A1–A5) in reactions using
PjTA-R6 were generally better than those with CvTA and Vf TA. For the production of A5, PjTA-R6
and CvTA displayed comparable results (Table 1). The yields found with PjTA-R6 were better in case
of straight-chain aliphatic amines with shorter chains (A1–A2) than with amines with larger groups
(A3–A5). In contrast, Vf TA showed an improving trend in yields with an increasing chain length of the
target amines. A previous study on the activity of Vf TA toward a set of alkyl substrates also showed
that the longer the side chain, the higher the activity [27]. For CvTA, no such trend was found. For
the production of A1–A3, PjTA-R6 generated higher yields by 28% or more than CvTA, while Vf TA
gave the lowest yields. The yields of A4 and A5 obtained with the three enzymes differed by less than
11%. The general advantage of asymmetric synthesis using PjTA-R6 was also clear from its better
enantioselectivity. Whereas CvTA and Vf TA produced linear aliphatic amines with e.e. <94%, all
amines formed by PjAT-R6 had better than 94% e.e.
For amines with branched carbon chains (B1–B3) and cycloalkene groups (C1–C2), PjTA-R6
generated high product yields, similar to those of amines with linear substituents (Table 1). In particular,
B1 was produced with 95% yield, which was the highest yield obtained with PjTA-R6. The advantage of
PjTA-R6, compared with CvTA and Vf TA, was again apparent from the higher yields. The conversion
of amines with nonlinear substituents by CvTA and Vf TA was not successful. This suggests that the
presence of a nonlinear large rest group in the substrate prevents proper accommodation of the ketone
or subsequent reaction intermediates in these enzymes. Overall, PjTA-R6 had a better performance in
yield and excellent enantioselectivity, which makes PjTA-R6 a promising candidate for the asymmetric
amination of aliphatic ketones. The difference between the three enzymes can be due to kinetic and
stability effects. Differences observed for the same enzyme should be attributed to kinetic differences,
unless conversion is very high when equilibrium may be approached (Table 1, PjTA-R6 with A2
and B1). For the branched and cyclic substrates (B1–B3, C1, and C2), which were well converted by
PjTA-R6 but poorly converted by CvTA and Vf TA, low intrinsic catalytic activity of the latter two
enzymes must be the cause of the observed differences.
2.2. Role of Switching Arginine
As mentioned, the native substrate of PjTA is the caprolactam biodegradation intermediate
6-aminohexanoic acid (6-AHA) [22]. The crystal structure of PjTA complexed with the external
aldimine formed from this substrate unveils that the carboxylate group forms a salt bridge with a
conserved arginine residue (Arg417) in the large pocket, probably contributing to substrate binding [23].
The arginine side chain switches toward a more outward position upon 6-AHA binding. Arg417 and
most surrounding residues were kept during the thermostability engineering that yielded PjTA-R6 [24].
During the redesign of other class III (S)-selective transaminases, the switching arginine is mostly
preserved as amino donors or acceptors often feature a carboxylate functionality [27–29]. However, in
Vf TA, Arg415 has been mutated to open up more space in the large pocket [27,29,30]. For the synthesis
of aliphatic alkylamines with IPA as amino donor, neither Arg415 nor Arg417 of Vf TA and PjAT-R6,
respectively, are required, and the iminium group can even produce repulsive interactions.
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To examine whether Arg417 still has a role in substrate binding when using isopropylamine as
amino donor and an amino acceptor substrate lacking a carboxylate functionality, the R417L mutant
of PjTA-R6 was prepared and tested in the same reaction scheme as for PjTA-R6. Thermal shift
fluorescence assays showed that the thermostability of the R6-R417L enzyme was similar to that of
the parent PjTA-R6 (∆Tmapp <1 ◦C). The yields of the enzymatic amination using the mutant R417L
remained at the same level as that of PjTA-R6. Yields of A1 and A2 obtained with R6-R417L (60% and
69%, respectively) were only slightly lower than that with PjTA-R6 (70% and 80%). As for A3–A5,
the yields obtained with R6-R417L (54%, 50%, and 47%) were very close to the yields with PjTA-R6.
Apparently, the positive charge of the arginine did not hinder activity with the apolar aliphatic acceptors
tested here. A possible explanation is conformational flexibility of the aliphatic group of the substrates
or of the Arg417, which may avoid close contact with the positively charged iminium function, unlike
what is observed in the 6-AHA-bound PjTA structure [23]. We anticipate that Arg417 can be replaced
for future engineering needs, e.g., aimed at expanding the binding site for more bulky substrates.
2.3. Structure–Activity Relationship Obtained by Docking
Accommodation of the external aldimine docking complexes formed with different substrates by
PjTA-R6 and Vf TA were examined to find a structural explanation for the observed activity profiles
(Table 1). The substrate-binding pockets of these TAs were positioned at the dimeric interface and
consisted of residues from both subunits. Because the small substituent of the tested molecules was
always a methyl group, the structure of the binding pocket that accommodates the large substituent was
crucial for differences in substrate specificity. The large binding pocket accommodated the carboxyalkyl
moiety or large substituent of 6-AHA in PjTA and the phenyl substituent of (S)-1-phenylethylamine
in Vf TA. Structural alignment of PjTA-R6 with CvTA (40% sequence identity, RMSD 1.28 Å) and
with Vf TA (41% sequence identity, RMSD 1.20 Å) indicated a high overall similarity, although with
local differences in the large binding pockets (Figure 1). The side chains of Leu57, Tyr151, Arg417,
Met419, Ala230, Trp58, Val260, and Ile261 formed a largely nonpolar binding pocket in PjTA-R6.
The corresponding pockets of CvTA and Vf TA were also hydrophobic. To examine the features that
potentially led to variations in substrate specificities and conferred PjTA-R6 with high reactivity toward
a variety of bulky amines, structures of enzyme complexed with product-derived external aldimines
were generated by Rosetta docking.
Figure 1. Schematic representation of the binding pocket of PjTA-R6 bearing the external aldimine
intermediate (PLP Schiff base with (S)-1-phenylethylamine) and comparison of surrounding residues
to CvTA and Vf TA. The residues in the large binding pocket are in blue. The residues colored red are in
the small binding pocket.
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The Rosetta interface energies obtained from docking the external aldimine complexes of the 10
different substrates showed a clear correlation with the experimental data observed for both Vf TA and
PjTA-R6 (Figure 2). Nevertheless, outliers were present in both plots. The most prominent outlier in
the Vf TA dataset was compound B3, which exhibited a higher docking score than would be expected
based on the experimental yield. B3 was also one of the three outliers in PjTA-R6, along with A4
and A5. The latter two were the only two compounds in the PjTA-R6 dataset where the switching
arginine Arg417 in the docking complex was kept in a crystal-like “out” conformation (discussed later),
whereas all the other compounds (A1–A3, B1–B3, and C1–C2) showed Arg417 in an “in” conformation.
The lower than expected yield for A5 with PjTA-R6 might also be due to the higher concentration
of dimethyl sulfoxide (DMSO) used to dissolve this substrate. The correlation between interface
energies and experimental yields suggested that structural differences in the binding pockets could
have accounted for most of the observed differences in activity within a set of substrates tested with
the same enzyme. Because at least one substrate for each enzyme was very well converted, low yields
for several substrates, such as B1–C2 for CvTA and Vf TA, must be due to kinetic causes rather than
rapid enzyme inactivation. However, differences in obtained yields between different enzymes might
be related to both kinetic and stability differences under the reaction conditions.
Figure 2. Interface energies of external aldimine complexes show a correlation with the observed
activities. (A) PjTA-R6 and (B) Vf TA. Outliers (red dots) were not considered for the linear regression
(dotted line). For PjTA-R6, this means the regression was made using compounds A1, A2, A3, B1, B2,
C1, and C2. In the case of Vf TA, B1, B2, C1, and C2 were not considered for the linear regression as the
product was hardly detectable (<2%). The Rosetta interface energy correctly predicted that B2, C1, and
C2 would have very low yields; hence, these compounds were not outliers.
The activity data suggested that PjTA-R6 could accommodate bulkier substituents than Vf TA
(Table 1). The docking simulations revealed that the conformational freedom of the switching
arginine played a large role in the ability of PjTA-R6 to accommodate bulky substrates. In both
Vf TA and PjTA-R6, the switching arginine (Arg415 and Arg417, respectively) could adopt one of two
conformations that allowed the binding of hydrophobic substituents in the large pocket (Figure 3).
We labeled these Arg conformations as “in” and “out” to indicate whether the guanidium group
was pointing inward (toward) the PLP or outward. The “in” and “out” arginine conformations in
Vf TA and PjTA-R6, respectively, were crystallized. In the known Vf TA structures (PDB codes: 4E3Q,
4E3R, 5ZTX, and 3NUI), Arg415 was stabilized in the inward conformation by a hydrogen bond with
Trp57. As such, the “in” conformation appeared to be the most stable for the PLP-bound enzyme and
the apo-enzyme. On the other hand, the “out” arginine conformation prevailed in the known PjTA
structures (PDB codes: 6TB1, 6TB0, 6G4B, 6G4C, 6G4D, 6G4E, and 6G4F), where Arg417 was stabilized
by electrostatic interactions, either with Ser87 in the wild-type PjTA or with Asn87 in PjTA-R6. In
PjTA-R6, Ser87 has been mutated to Asn to improve the enzyme’s thermostability [15,16]. The natural
substrate of PjTA is 6-AHA, where the role of the switching arginine is to form a salt bridge with
the carboxyl group of the substrate (code: 6G4E). PjTA-R6 and Vf TA exhibited structurally different
“in” and “out” Arg conformations. The outward conformation in Vf TA placed the Arg415 side chain
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in a sandwich-like configuration between Trp57 and Asn53, reducing the ability of Trp57 to freely
rotate in response to the presence of a bulky substrate. On the other hand, the “out” conformation
of PjTA-R6 moved Arg417 away from the binding pocket, locking Arg417 with Asn87 via a polar
interaction, thereby both opening up more space in the large pocket and allowing free rotation of Trp58.
The inward conformations of Arg415/Arg417 in Vf TA and PjTA-R6 could also account for the difference
in reactivity toward bulky substrates. In the “in” conformation, the switching arginine of PjTA-R6
made hydrogen bonding contacts with the backbone of Ala230, leaving enough space in the large
pocket for bulky substituents. In contrast, Vf TA locked Arg415 with the indole amino group of Trp57
via hydrogen-bonding interactions, offering less space in the large pocket. Mutations of Trp57 have
been carried out, yielding good reactivities toward both alkyl and aromatic substrates [20]. Arg415
from Vf TA could not reach the backbone of the equivalent Ala228 due to the presence of Leu417, which
corresponded to Met419 in PjTA-R6. These differences in both the “in” and “out” conformations can
explain the distinct catalytic performance of the two enzymes toward bulky substrates.
Figure 3. Docked external aldimine structures of 3,3-dimethyl-2-butylamine B2, representative of a
products with bulky substituents. (A) In PjTA-R6, the tert-butyl substituent can be easily accommodated
in the large pocket by a 40◦ rotation of Trp58 (yellow arrow). Arg417 does not induce protein–ligand
clashes in either the “in” or the “out” orientation. (B) In Vf TA, both the “in” and the “out” conformations
of Arg415 prevent a rotation of Trp57 necessary to accommodate the tert-butyl substituent. In both
panels, protein structures are shown in licorice representation, and the crystal structure conformations
of residues Arg417/Arg415 and Trp58/Trp57 are colored magenta (PDBs 4Q3H for Vf TA and 6TB1 for
PjTA-R6). The external aldimine structure of B2 is shown in CPK representation. Figures were rendered
using VMD (Visual Molecular Dynamics).
An additional difference between PjTA-R6 and Vf TA was the effect of increasing the chain length
of the alkyl substituent on activity (i.e., substrates A1–A5). The experimental data showed that longer
alkyl substituents negatively impacted conversion by PjTA-R6 (Table 1). On the contrary, Vf TA (and
CvTA) showed better activities with longer alkyl substituents, as also found by Cho et al. in a study
aimed at redesigning the substrate specificity of Vf TA [27]. Rosetta-generated docking models of the
external aldimine intermediates of A1–A5 indicated that Vf TA accommodated the increasingly longer
alkyl chain in the large pocket by pointing the terminal methyl group of the alkyl chain toward the entry
tunnel (Figure 4B). In the case of PjTA-R6, the equivalent space was partially blocked by Arg417 in both
the “in” and “out” conformations. The terminal methyl group of the alkyl chain of A4 and A5 was still
perfectly able to fit in the large pocket of PjTA-R6, albeit less favorably (Figure 4A) than compounds
with shorter alkyl substituents (i.e., A1–A3). The negative effect of Arg417 on the activity of PjTA-R6
was minor, as demonstrated by the fact that mutation R417L offered only a marginal improvement
in the yields of amines A4 and A5. Furthermore, the large pocket of PjTA-R6 contained more polar
residues than Vf TA, thereby offering a less suitable environment to accommodate the lengthening alkyl
chain of the A1–A5 series. All in all, while the catalytic activity of PjTA-R6 decreased for long alkyl
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chains, PjTA-R6 still gave higher yields and higher enantioselectivities than Vf TA, making PjTA-R6
valuable for synthesis of enantiopure alkyl amines.
Figure 4. Docking structures of the external aldimine intermediates of amines A1–A5. (A). PjTA-R6
and (B) Vf TA. The “out” conformation of the switching arginine is preferred for longer substituents (A4
and A5), whereas the shorter alkyl substituents (A1 to A3) show no preference for either conformation.
The large binding site of PjTA-R6 is less hydrophobic than the binding site of Vf TA (N87, Y20, and
F86 for PjTA-R6 and F86, F19, and F85 for Vf TA, respectively). The superimposed external aldimine
structures of A1–A5 are shown in CPK representation. The “in” conformation of Arg417/Arg415 is
colored magenta.
3. Materials and Methods
3.1. Materials
Isopropylamine, amines (A1–A5, B1–B3, and C1–C2), and the corresponding ketones were
purchased from Sigma-Aldrich (St. Louis, MO, USA) or Acros Organics (Fair Lawn, NJ, USA). PLP was
purchased from Fisher Scientific (Pittsburgh, PA, USA). Other chemicals were from the same suppliers
or Merck Millipore (Burlington, MA, USA).
3.2. Enzyme Expression and Purification
The design, isolation, and properties of the PjTA-R6 mutant have been previously described [24].
The PjTA-R6-R417L mutant was created by QuikChange site-directed mutagenesis. Primers were
designed by the QuikChange Primer Design Program of Agilent Technologies (Santa Clara,
CA, USA). The mutations were verified by DNA sequencing (Eurofins Genomics, Ebersberg,
Germany). After sequencing, the mutated plasmids were transformed into E. coli BL21(DE3) for
expression. The expression and purification of PjTA-R6, PjTA-R6-R417L, CvTA, and Vf TA were
performed as previously described. Specific activities of purified enzymes in the deamination
of (S)-1-phenylethylamine were 47 U/mg (at 70 ◦C, spectrophotometric acetophenone production
assay [24]) or 1.6 and 1.0 U/mg (at 30 ◦C, coupled enzyme assay using pyruvate as amino acceptor [23])
for PjTA, CvTA, and Vf TA, respectively.
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3.3. Thermal Shift Assay
Apparent melting temperatures (Tmapp) were determined by fluorescence-based thermofluor
assay [31]. Specifically, samples of 5 µL 50-fold diluted SYPRO orange and 20 µL 0.5 mg/mL enzyme
solution were added to an IQ 96-well PCR plate (Bio-Rad, Hercules, CA, USA) and mixed thoroughly
in the wells. The plates were sealed with Microseal B adhesive sealer (Bio-Rad, USA) and heated from
20 to 99 ◦C in a MyiQ real-time PCR machine (Bio-Rad, USA) with a linear gradient of increasing
temperature (1 ◦C/min). The temperature at the maximum rate of fluorescence change (dRFU/dT) was
taken as Tmapp [32].
3.4. Amination Reactions and Product Derivatization
Enzyme reactions were carried out in a 1 mL reaction system containing 50 mM potassium
phosphate, pH 8.0, with 20 mM ketone substrate, 1 M isopropylamine, 0.5 mM PLP, 1 mg/mL enzyme,
and 2% DMSO (20% for A5). Reactions were started by addition of substrate and carried out at 56 ◦C
for PjTA-R6 and R417L and 37 ◦C for CvTA and Vf TA over 20 h. Reactions were stopped by adding
200 µL 10 M NaOH, after which 100 µL samples were taken from the basified solutions and extracted
once with 300 µL ethyl acetate.
For derivatization, the organic layer was supplied with 300 µL acetic anhydride and
4-dimethylaminopyridine (DMAP) [1], and the solution was shaken at room temperature and 450 rpm
for 1 h. Following washing with 500 µL water, the organic layer containing the derivatized product
was collected and dried over magnesium sulfate.
3.5. Quantification and Optical Purity
The derivatized products were analyzed by gas chromatography with flame ionization detection
on a heptakis-(2,6-di-O-methyl-3-O-pentyl)-β-cyclodextrin column using He at a flow rate of 1 mL/min.
The following settings were applied to the analysis of all products and their corresponding commercial
references: temperature program: 80 ◦C for 6.5 min, 10 ◦C/min to 160 ◦C, and 20 ◦C/min to 200 ◦C for
10 min; total run time: 26.5 min; inlet temperature: 220 ◦C; and injection volume: 1 µL. To quantify
the product, the peaks of the enantiomers were summed up and compared with a commercial
amine reference (see Supplementary Materials). To analyze the optical purity of the products,
the peaks of different enantiomers were mostly identified with commercial chiral amine references
(see Supplementary Materials). The e.e. values were calculated from the peak areas of the (S)- and
(R)-amines.
3.6. Computational Modeling
The coordinates for the (S)-amino products of the tested compounds (A1–A5, B1–B3, and C1–C2)
were generated in Avogadro (Hanwell et al., 2012; https://avogadro.cc/) [26] from their respective
SMILES (Simplified Molecular Input Line Entry System) string and optimized by 500 steps of steepest
descent energy minimization in the MMFF94 force field. The initial coordinates for the external aldimine
forms of the tested substrates were created by superimposing the amino group of the abovementioned
(S)-amino products to the amino group of the PLP cofactor, whose coordinates were obtained from
the crystal structure (PDB: 4E3Q). After superimposition, one of the nitrogen atoms was deleted (the
cofactor’s), and a covalent bond was added between C4′ and the remaining nitrogen atom (the amino
substrate’s) to form the corresponding Schiff base. A rotamer library for each ligand was generated
in YASARA [33]. For each external aldimine structure, 1000 rotamers were generated by random
perturbation of the heavy-atom dihedrals (SampleDih YASARA routine) while maintaining the cofactor
atoms frozen. Pairwise RMSD (root-mean-square deviation) between all rotamers within each library
was used for selecting unique rotamers (cutoff <0.05 Å), resulting in 200–300 unique rotamers for
each ligand.
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Structure coordinates for PjTA-R6 [24] and Vf TA [30] were obtained from the PDB databank (6TB1
and 4E3Q, respectively). The crystal structures were prepared for docking by first implementing the
CleanObj YASARA routine, which added explicit hydrogens to the structure, and converting Se-Met
residues into canonical Met. Protonation states of residues Asp, Glu, His, and Lys were calculated
by an automatic YASARA routine at pH 7 [33]. The resulting scaffold structure was stripped of any
nonprotein residues.
The scaffold protein structure was relaxed by the Rosetta (v2020.11) Relax [34] algorithm with the
following command-line arguments: -ignore_unrecognized_res, -relax:constrain_relax_to_start_coords,
-relax:coord_constrain_sidechains, -relax:ramp_constraints false, -use_input_sc, -correct,
-no_his_his_pairE, -no_optH false, -flip_HNQ. Binding poses of external aldimine complexes
were generated using the Rosetta Enzyme Design application [35]. One randomly selected rotamer
from each conformer library was overlapped to the binding site (subunit A) of PjTA-R6 or Vf TA by
RMSD alignment to the cofactor heavy atoms. The resulting structure served as input for the docking
calculations. During the docking simulations, residues with Cα closer than 10 Å from any ligand
heavy atom were allowed to repack. For PjTA-R6, residues 20, 87, 59, 118, 119, 151, 152, 225, 259,
287, 292, and 324 were set to NATRO (natural rotamer, kept fixed). For Vf TA, residues 19, 53, 115,
118, 121, 150, 151, 256, 258, and 322 were set to NATRO. No constraints were used in the production
runs. Additionally, the following command-line arguments were used for the Rosetta docking:
-enzdes, -cst_predock, -cst_design, -cut1 0.0 -cut2 0.0, -cut3 8.0, -cut4 10.0, -cst_min, -chi_min, -bb_min,
-packing::use_input_sc, -packing::soft_rep_design, -design_min_cycles 3, -ex1:level 4, -ex1:level 4,
-ex1aro:level 4, -ex2aro:level 4. A total of 200 docking complexes were generated for each ligand, and
the average interface energies were computed and compared against the experimental yield. Figures
were generated using VMD (http://www.ks.uiuc.edu/Research/vmd/).
4. Conclusions
PjTA-R6 was capable of converting various aliphatic ketones into the corresponding amines with
good activity, including when compared to CvTA and Vf TA. The scope of aliphatic amines that can be
asymmetrically synthesized spans from amines with linear (A1–A5) or branched substituents (B1–B3)
to lesser studied amines with a cycloalkyl moiety (C1–C2). The enantioselectivity of PjTA-R6 was
ideal for most cases, which plays in favor of using this enzyme for chiral amine production. PjTA-R6
catalyzed amination at a relatively high temperature (56 ◦C). Its robustness allows use of the enzyme
under beneficial conditions for enzymatic amination, e.g., high temperature, higher amino donor
concentration, and presence of cosolvent for better substrate and product solubility. The mutant
R6-R417L showed a comparable performance to PjTA-R6, indicating that the switching arginine Arg417
is replaceable when a carboxylate functionality is absent from the keto substrate and the amino donor.
The interface energies obtained with Rosetta docking simulations of the external aldimine reaction
intermediates showed a clear correlation with yield in amine synthesis, both in case of PjTA-R6
and Vf TA. Further comparison of the docked structures unveiled differences in the conformations
of the switching arginine that interacts with the native substrates of PjTA-R6 and Vf TA. In Vf TA,
the conformational freedom of the switching arginine is more restricted than in PjTA-R6 and does
not allow Vf TA to accommodate bulky substrates. Overall, the binding site of PjTA-R6 is better at
adapting to fit bulkier substituents than the related enzyme Vf TA. The observation that the relative
reactivity of PjTA-R6 can be rationalized by docking simulations and energy calculations suggests
that these computational tools can support the design of variants with expanded or shifted substrate
spectrum, which is important for furthering applicability in green chemistry.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4344/10/11/1310/s1,
Figure S1: The chromatograms of 20, 2, and 0.2 mM A3 sample after derivatization; Figure S2: Representative
chromatogram of PjTA-R6-catalyzed transamination of 2-butanone yielding sec-butylamine (A1) after product
derivatization; Figure S3: Representative chromatogram of PjTA-R6-catalyzed transamination of 2-pentanone
yielding 2-aminopentane (A2) after product derivatization; Figure S4: Representative chromatogram of
PjTA-R6-catalyzed transamination of 2-hexanone yielding 2-aminohexane (A3) after product derivatization.
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Figure S5: Representative chromatogram of PjTA-R6-catalyzed transamination of 2-heptanone yielding
2-aminoheptane (A4) after product derivatization; Figure S6: Representative chromatogram of PjTA-R6-catalyzed
transamination of 2-octanone yielding 2-aminooctane (A5) after product derivatization; Figure S7: Representative
chromatogram of PjTA-R6-catalyzed transamination of 3-methyl-2-butanone yielding 3-methyl-2-butanamine
(B1) after product derivatization; Figure S8: Representative chromatogram of PjTA-R6-catalyzed transamination
of 3,3-dimethyl-2-butanone yielding 3,3-dimethyl-2-butanamine (B2) after product derivatization; Figure S9:
Representative chromatogram of PjTA-R6-catalyzed transamination of 4-methyl-2-pentanone yielding
4-methyl-2-pentanamine (B3) after product derivatization; Figure S10: Representative chromatogram of
PjTA-R6-catalyzed transamination of 1-cyclopropylethanone yielding 1-cyclopropylethanamine (C1) after
product derivatization; Figure S11: Representative chromatogram of PjTA-R6-catalyzed transamination of
1-cyclohexylethanone yielding 1-cyclohexylethanamine (C2) after product derivatization; Figure S12: SDS-PAGE
analysis of purified CvTA, Vf TA, and PjTA-R6; Table S1: The retention times of the derivatized products.
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